Tom A Bäck (Tom Bäck)

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2020
Publications (10 Years): 1

Top Topics

Prostate Cancer

Monoclonal Antibody

Body Composition

Top Venues

EJNMMI research

University of Gothenburg

University of Gothenburg (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Gothenburg Jul 01 2011

Sweden

Researcher :: Department of Radiation Physics

Education History

University of Gothenburg Dec 17 2007 - Jun 21 2011

Sweden

PHD :: Department of Radiation Physics

University of Gothenburg Aug 15 1983 - Jun 15 1986

Sweden

BSC :: Clinical Physiology

Publications

Tom A Bäck, Karin Jennbacken, Malin Hagberg Thulin, Sture Lindegren, Holger Jensen, Tove Olafsen, Paul J Yazaki, Stig Palm, Per Albertsson, Jan-Erik Damber, Anna M Wu, Karin Welén
Targeted alpha therapy with astatine-211-labeled anti-PSCA A11 minibody shows antitumor efficacy in prostate cancer xenografts and bone microtumors. EJNMMI research 10 (1) (2020)
Damian J Green, Mazyar Shadman, Jon C Jones, Shani L Frayo, Aimee L Kenoyer, Mark D Hylarides, Donald K Hamlin, D Scott Wilbur, Ethan R Balkin, Yukang Lin, Brian W Miller, Sofia H L Frost, Ajay K Gopal, Johnnie J Orozco, Theodore A Gooley, Kelly L Laird, Brian G Till, Tom A Bäck, Brenda M Sandmaier, John M Pagel, Oliver W Press
Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model. Blood 125 (13) (2015)